Core Laboratories (NYSE:CLB) Releases Q3 2026 Earnings Guidance

Core Laboratories (NYSE:CLB) updated its third quarter 2026 earnings guidance on Wednesday. The company provided EPS guidance of 0.120-0.200 for the period, compared to the consensus earnings per share estimate of 0.170. The company issued revenue guidance of $128.5 million-$135.5 million, compared to the consensus revenue estimate of $132.5 million.

Core Laboratories Stock Performance

Core Laboratories stock traded up $0.53 on Thursday, reaching $10.40. 672,715 shares of the stock were exchanged, compared to its average volume of 590,187. The stock has a market cap of $479.44 million, a PE ratio of 15.85, a PEG ratio of 2.58 and a beta of 1.00. Core Laboratories has a twelve month low of $9.72 and a twelve month high of $20.36. The firm has a fifty day moving average price of $12.17 and a two-hundred day moving average price of $15.32. The company has a current ratio of 2.05, a quick ratio of 1.50 and a debt-to-equity ratio of 0.42.

Core Laboratories (NYSE:CLB) last issued its earnings results on Wednesday, July 29th. The oil and gas company reported $0.11 earnings per share for the quarter, beating the consensus estimate of $0.08 by $0.03. Core Laboratories had a net margin of 5.94% and a return on equity of 11.52%. The business had revenue of $124.61 million for the quarter, compared to analyst estimates of $126.26 million. During the same period in the previous year, the business earned $0.19 EPS. The firm’s revenue was down 4.3% on a year-over-year basis. Core Laboratories has set its Q3 2026 guidance at 0.120-0.200 EPS. Sell-side analysts anticipate that Core Laboratories will post 0.53 EPS for the current year.

Core Laboratories Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, August 31st. Shareholders of record on Monday, August 10th will be paid a $0.01 dividend. The ex-dividend date is Monday, August 10th. This represents a $0.04 annualized dividend and a yield of 0.4%. Core Laboratories’s payout ratio is presently 6.15%.

Wall Street Analyst Weigh In

A number of brokerages have commented on CLB. Weiss Ratings lowered Core Laboratories from a “hold (c-)” rating to a “sell (d+)” rating in a report on Wednesday, June 24th. Wall Street Zen lowered Core Laboratories from a “hold” rating to a “sell” rating in a research note on Saturday, July 4th. One equities research analyst has rated the stock with a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Reduce”.

Institutional Investors Weigh In On Core Laboratories

Several institutional investors have recently made changes to their positions in CLB. Barclays PLC boosted its stake in Core Laboratories by 9.5% in the 4th quarter. Barclays PLC now owns 73,246 shares of the oil and gas company’s stock worth $1,174,000 after purchasing an additional 6,379 shares during the period. Old West Investment Management LLC purchased a new position in Core Laboratories during the fourth quarter valued at approximately $613,000. Balyasny Asset Management L.P. purchased a new position in Core Laboratories during the second quarter valued at approximately $586,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in Core Laboratories by 4.4% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 27,893 shares of the oil and gas company’s stock worth $418,000 after acquiring an additional 1,170 shares during the period. Finally, Two Sigma Investments LP lifted its stake in Core Laboratories by 20.3% in the 3rd quarter. Two Sigma Investments LP now owns 30,551 shares of the oil and gas company’s stock worth $378,000 after purchasing an additional 5,160 shares in the last quarter. Hedge funds and other institutional investors own 97.81% of the company’s stock.

Core Laboratories Company Profile

Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.

The company’s portfolio spans two primary service lines: reservoir description and production enhancement.